"Having Dr Ian Valerio visit Australia last week was a significant milestone for Orthocell. As a plastic reconstructive and trauma surgeon at Massachusetts General Hospital, Harvard professor, and US Navy Captain, Dr Valerio represents the finest calibre of clinical expertise in the world's largest nerve repair market.
"This interview perfectly captures why his endorsement matters. Dr Valerio not only understands the technical aspects of our technology, but he is able to explain its value in a way that resonates across audiences from fellow surgeons to investors and to patients.
"The US market represents our biggest opportunity for growth, and having Key Opinion Leaders like Dr Valerio’s support gives us tremendous confidence in our expansion strategy."
Paul Anderson
OCC Price at posting:
$1.27 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)